Thijs A. Lilien

Dr. Thijs A. Lilien


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TLThijs A. Lilien
Thijs A. Lilien
NGNina S. Groeneveld
Nina S. Groeneveld
FEFaridi van Etten-Jamaludin
Faridi van Etten-Jamaludin
MPMark J. Peters
Mark J. Peters
CBCorinne M. P. Buysse
Corinne M. P. Buysse
RBReinout A. Bem
Reinout A. Bem
The administration of supplemental oxygen is a cornerstone treatment in critically ill patients to prevent and resolve cellular hypoxia. Although oxygen therapy can be lifesaving on many occasions, its overzealous use may lead to supraphysiological levels of the Pao2 (ie, hyperoxia), which is associated with deleterious outcomes. For example, in critically ill adults, arterial hyperoxia has been associated with increased mortality, most pronounced at extreme levels of Pao2.1,2 Detrimental effects of hyperoxia may derive from increased formation of reactive oxygen species, which damage biomolecules, or from its pulmonary and vascular complications, such as atelectasis and hyperoxemic vasoconstriction.3-7

1 July 2023 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
TLThijs A. Lilien
Thijs A. Lilien
DMDavid M. P. van Meenen
David M. P. van Meenen
MSMarcus J. Schultz
Marcus J. Schultz
LBLieuwe Bos
Lieuwe Bos
Reinout A. BemReinout A. Bem
Reinout A. Bem
Over the past decade, the interest in oxygen toxicity has led to various observational studies and randomized clinical trials in critically ill patients, assessing the association with outcomes and the potential benefit of restrictive oxygenation targets. Yet to date, no consensus has been reached regarding the clinical impact of hyperoxia and hyperoxemia. In this perspective article, we explore the experimental and clinical evidence on hyperoxia-induced lung injury (HILI) and assess its relative impact in current critical care practice, specifically in patients who require oxygen therapy due to acute respiratory distress syndrome (ARDS). Here, we suggest that in current clinical practice in the setting of ARDS HILI may actually be of less importance than other ventilator-related factors.

19 August 2025 in Anaesthesia
Verified
Journal Article
Open access
Lukas Martin Müller-WirtzLukas Martin Müller-Wirtz
Lukas Martin Müller-Wirtz
TLThijs A. Lilien
Thijs A. Lilien
WPWilliam M. Patterson
William M. Patterson
SOSascha Ott
Sascha Ott
RFRoland C. E. Francis
Roland C. E. Francis
FIfor the REPEAT investigators
for the REPEAT investigators
Summary: Introduction: Intra‐operative supplemental oxygen and mechanical ventilation expose the lungs to potentially injurious energy. This can be quantified as ‘chemical power’ and ‘mechanical power’, respectively. In this study, we sought to determine if intra‐operative chemical and mechanical power, individually and/or in combination, are associated with postoperative pulmonary complications. Methods: Using an individual patient data analysis of three randomised clinical trials of intra‐operative ventilation, we summarised intra‐operative chemical and mechanical power using time‐weighted averages. We evaluated the association between intra‐operative chemical and mechanical power and a collapsed composite of postoperative pulmonary complications using multivariable logistic regression to estimate the odds ratios related to the effect of 1 J.min ‐1 increase in chemical or mechanical power with adjustment for demographic and intra‐operative characteristics. We also included an interaction term to assess for potential synergistic effects of chemical and mechanical power on postoperative pulmonary complications. Results: Of 3837 patients recruited to three individual trials, 2492 with full datasets were included in the analysis. Intra‐operative time‐weighted average (SD) chemical power was 10.2 (3.9) J.min ‐1 and mechanical power was 10.5 (4.4) J.min ‐1 . An increase of 1 J.min ‐1 in chemical power was associated with 8% higher odds of postoperative pulmonary complications (OR 1.08, 95%CI 1.05–1.10, p < 0.001), while the same increase in mechanical power raised odds by 5% (OR 1.05, 95%CI 1.02–1.08, p = 0.003). We did not find evidence of a significant interaction between chemical and mechanical power (p = 0.40), suggestive of an additive rather than synergistic effect on postoperative pulmonary complications. Discussion: Both chemical and mechanical power are independently associated with postoperative pulmonary complications. Further work is required to determine causality.

7 December 2022 in Pediatric Critical Care Medicine
Verified
Journal Article
Open access
TLThijs A. Lilien
Thijs A. Lilien
ESEleonore S. V. de Sonnaville
Eleonore S. V. de Sonnaville
JWJob B. M. van Woensel
Job B. M. van Woensel
RBReinout A. Bem
Reinout A. Bem
OBJECTIVES: Oxygen supplementation is a cornerstone treatment in critically ill children with bronchiolitis in the PICU. However, potential deleterious effects of high-dose oxygen are well-known. In this study, we aim to describe the pulmonary (local) and arterial (systemic) oxygen exposure over the duration of invasive mechanical ventilation (IMV) in children with severe bronchiolitis. Our secondary aim was to estimate potentially avoidable exposure to high-dose oxygen in these patients. DESIGN: Retrospective cohort study. SETTING: Single-center, tertiary-care PICU. PATIENTS: Children younger than 2 years old admitted to the PICU for severe bronchiolitis receiving IMV. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Hourly measurements of Fio 2 and peripheral oxygen saturation (Spo 2), and arterial blood gas data were collected up to day 10 of IMV. A total of 24,451 hours of IMV were observed in 176 patients (median age of 1.0 mo [interquartile range (IQR), 1.0–2.3 mo]). The pulmonary exposure to oxygen was highest during the first day of IMV (median time-weighted average [TWA]–Fio 2 0.46 [IQR, 0.39–0.53]), which significantly decreased over subsequent days. The systemic exposure to oxygen was relatively low, as severe hyperoxemia (TWA–Pao 2 > 248 Torr [> 33 kPa]) was not observed. However, overuse of oxygen was common with 52.3% of patients (n = 92) having at least 1 day of possible excessive oxygen exposure and 14.8% (n = 26) with severe exposure. Furthermore, higher oxygen dosages correlated with increasing overuse of oxygen (rrepeated measures, 0.59; 95% CI, 0.54–0.63). Additionally, caregivers were likely to keep Fio 2 greater than or equal to 0.50 when Spo 2 greater than or equal to 97%. CONCLUSIONS: Moderate to high-dose pulmonary oxygen exposure and potential overuse of oxygen were common in this cohort of severe bronchiolitis patients requiring IMV; however, this was not accompanied by a high systemic oxygen burden. Further studies are needed to determine optimal oxygenation targets to prevent overzealous use of oxygen in this vulnerable population.

12 February 2024 in Intensive Care Medicine Experimental
Verified
Journal Article
Open access
PDF file
TLThijs A. Lilien
Thijs A. Lilien
DFDominic W. Fenn
Dominic W. Fenn
PBPaul Brinkman
Paul Brinkman
LHLaura A. Hagens
Laura A. Hagens
MSMarry R. Smit
Marry R. Smit
RSRonny M. Schnabel
Ronny M. Schnabel
Background: Exhaled volatile organic compounds (VOCs), particularly hydrocarbons from oxidative stress-induced lipid peroxidation, are associated with hyperoxia exposure. However, important heterogeneity amongst identified VOCs and concerns about their precise pathophysiological origins warrant translational studies assessing their validity as a marker of hyperoxia-induced oxidative stress. Therefore, this study sought to examine changes in VOCs previously associated with the oxidative stress response in hyperoxia-exposed lung epithelial cells. Methods: A549 alveolar epithelial cells were exposed to hyperoxia for 24 h, or to room air as normoxia controls, or hydrogen peroxide as oxidative-stress positive controls. VOCs were sampled from the headspace, analysed by gas chromatography coupled with mass spectrometry and compared by targeted and untargeted analyses. A secondary analysis of breath samples from a large cohort of critically ill adult patients assessed the association of identified VOCs with clinical oxygen exposure. Results: Following cellular hyperoxia exposure, none of the targeted VOCs, previously proposed as breath markers of oxidative stress, were increased, and decane was significantly decreased. Untargeted analysis did not reveal novel identifiable hyperoxia-associated VOCs. Within the clinical cohort, three previously proposed breath markers of oxidative stress, hexane, octane, and decane had no real diagnostic value in discriminating patients exposed to hyperoxia. Conclusions: Hyperoxia exposure of alveolar epithelial cells did not result in an increase in identifiable VOCs, whilst VOCs previously linked to oxidative stress were not associated with oxygen exposure in a cohort of critically ill patients. These findings suggest that the pathophysiological origin of previously proposed breath markers of oxidative stress is more complex than just oxidative stress from hyperoxia at the lung epithelial cellular level.

12 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
TLThijs A. Lilien
Thijs A. Lilien
MGMiša Gunjak
Miša Gunjak
DMDespoina Myti
Despoina Myti
FCFrancisco Casado
Francisco Casado
Job B.M. van WoenselJob B.M. van Woensel
Job B.M. van Woensel
Reinout A. BemReinout A. Bem
Reinout A. Bem
Viral-induced lower respiratory tract infection (LRTI), mainly by respiratory syncytial virus (RSV), causes a major health burden among young children and has been associated with long-term respiratory dysfunction. Children with severe viral LRTI are frequently treated with oxygen therapy, hypothetically posing an additional risk factor for pulmonary sequelae. The main goal of this study was to determine the effect of concurrent hyperoxia exposure during the acute phase of viral LRTI on long-term pulmonary outcome. As an experimental model for severe RSV LRTI in infants, C57Bl/6J mice received an intranasal inoculation with the pneumonia virus of mice J3666 strain at post-natal day 7, and were subsequently exposed to hyperoxia (85% O2) or normoxia (21% O2) from post-natal day 10 to 17 during the acute phase of disease. Long-term outcomes, including lung function and structural development, were assessed 3 weeks post-inoculation at post-natal day 28. Compared to normoxic conditions, hyperoxia exposure in PVM-inoculated mice induced a transient growth arrest without subsequent catchup growth, as well as a long-term increase in airway resistance. This hyperoxia-induced pulmonary dysfunction was not associated with developmental changes to the airway or lung structure. These findings suggest that hyperoxia exposure during viral LRTI at young age may aggravate subsequent long-term pulmonary sequelae. Further research is needed to investigate the specific mechanisms underlying this alteration to pulmonary function.